Plant-based vaccines challenge big pharma for $3 billion flu market BY SHARON BEGLEY NEW YORK Wed Oct 1, 2014 2:17am EDT
Excerpt: "(Reuters) - Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.
The use of plants to produce life-saving pharmaceuticals captured global attention when it was revealed that the Ebola drug ZMapp is produced in the leaves of tobacco plants."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.